Close
Nordic 9Nordic 9

Northpond Ventures (investor - Venture Capital)

United States northpondventures.com
See something wrong or missing? Let us know
Offices:Bethesda
Average round investment:53.82M USD
Average number per year:2.0
Distribution: 2022 (4)2021 (1)2020 (1)
Portfolio companies: Switzerland Opna BioGermany MoleculeUnited Kingdom OMass Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (4) Health services (5)
See the entire list

Showing 3 of 6 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Northpond Ventures

Name Criteria
United Kingdom Aviva Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands BioGeneration Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Gimv
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Hitachi Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Ingka Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Novalis Biotech
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Israel Pontifax Venture Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Marketplace
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom SV Health Investors
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Turkey Revo Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Marketplace, Financial Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top